Tag: fault
-
CSA: Zero Trust Makes Security Everyone’s Responsibility
Source URL: https://hub.illumio.com/briefs/zero-trust-makes-cybersecurity-everyones-responsibility Source: CSA Title: Zero Trust Makes Security Everyone’s Responsibility Feedly Summary: AI Summary and Description: Yes Summary: The text discusses a significant cybersecurity incident involving unauthorized WiFi usage aboard the USS Manchester, emphasizing the need for a cultural shift toward shared cybersecurity responsibility within organizations. It highlights the Zero Trust model as…
-
Cloud Blog: AlloyDB for PostgreSQL: Two years of innovation and industry leadership
Source URL: https://cloud.google.com/blog/products/databases/reflecting-on-two-years-of-alloydb/ Source: Cloud Blog Title: AlloyDB for PostgreSQL: Two years of innovation and industry leadership Feedly Summary: Two years ago, on a mission to redefine enterprise-grade databases we released AlloyDB for PostgreSQL in production. We saw the immense popularity and flexibility of PostgreSQL — a database developers love for being open-source — and…
-
Cloud Blog: Elevate your workload resilience in console with data protection for Compute Engine
Source URL: https://cloud.google.com/blog/products/storage-data-transfer/console-gains-data-protection-interface-for-backup-and-dr/ Source: Cloud Blog Title: Elevate your workload resilience in console with data protection for Compute Engine Feedly Summary: Protecting your data in the cloud is more critical than ever. As your Google Cloud deployments grow, managing your data protection strategy for Compute Engine workloads can become complex. That’s why we’re excited to…
-
Cloud Blog: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE
Source URL: https://cloud.google.com/blog/products/ai-machine-learning/accelerate-ai-in-healthcare-nvidia-bionemo-gke/ Source: Cloud Blog Title: Accelerating AI in healthcare using NVIDIA BioNeMo Framework and Blueprints on GKE Feedly Summary: The quest to develop new medical treatments has historically been a slow, arduous process, screening billions of molecular compounds across decade-long development cycles. The vast majority of therapeutic candidates do not even make it…